✦ LIBER ✦

Clinical impact of genetic and molecular markers in myelodysplastic syndromes (MDS)

✍ Scribed by Peter Valent

Book ID: 107636659
Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 100 KB
Volume: 2
Category: Article
ISSN: 1865-5041
DOI: 10.1007/s12254-009-0098-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular genetic features of myelodyspl

Molecular genetic features of myelodysplastic syndromes (MDS)

✍ Willman, C L 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

International MDS risk analysis workshop

International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes

✍ Jelena M. Kao; Alex McMillan; Peter L. Greenberg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

## Abstract The International Prognostic Scoring System (IPSS) was created for evaluating clinical outcomes of patients with myelodysplastic syndromes (MDS). We evaluated the depth of cytopenias to determine whether this parameter could further refine the prognostic ability of the IPSS. Correlation

The incidence and impact of thrombocytop

The incidence and impact of thrombocytopenia in myelodysplastic syndromes

✍ Hagop Kantarjian; Francis Giles; Alan List; Roger Lyons; Mikkael A. Sekeres; She 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Abstract Thrombocytopenia and platelet dysfunction contribute to hemorrhagic complications in the myelodysplastic syndromes (MDS). Reliable data regarding the frequency and consequences of thrombocytopenia in MDS are lacking. An extensive literature review indicated that the prevalence of thromb

Changed concepts and definitions of myel

Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification

✍ Konnie M. Hebeda; F. Fend 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

Iron overload in myelodysplastic syndrom

Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform

✍ P. Valent; O. Krieger; R. Stauder; F. Wimazal; T. Nösslinger; W. R. Sperr; H. Si 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

The impact of cytomorphology, cytogeneti

The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes

✍ Ulrike Bacher; Torsten Haferlach; Wolfgang Kern; Tamara Weiss; Susanne Schnittge 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract ## BACKGROUND: Because of limited reproducibility of morphologic features, the morphological categorization of initial myelodysplastic syndromes (MDS) cases remains a major task in a diagnostic setting. ## METHODS: To further evaluate the role of additional diagnostic methods for sus